Revvity Inc
(BSP:R1VT34)
R$
23.77
0 (0%)
Market Cap: 81.00 Bil
Enterprise Value: 93.46 Bil
PE Ratio: 56.19
PB Ratio: 1.79
GF Score: 65/100 PerkinElmer Inc at Stifel Healthcare Conference Transcript
Nov 16, 2022 / 02:10PM GMT
Release Date Price:
R$23.21
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Welcome everybody. We are on the Life Sciences track of the Stifel Healthcare Conference here. I am here with Maxwell Krakowiak, CFO of PerkinElmer. Max, thanks for joining us here today.
Maxwell Krakowiak
PerkinElmer, Inc. - Senior VP & CFO
Thanks for having me Dan.
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Yes. For sure. You took the job 4 months ago as far as the CFO, but you have been at the company for about 4 years if I am getting that right. I'd like to just sort of ask how it's going.
Maxwell Krakowiak
PerkinElmer, Inc. - Senior VP & CFO
-It's going good. It's been a lot of fun so far. We got a couple of things going on a little bit, but it's busy, but it's been good.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot